/EMHTF
EMHTF Stock - Emerald Health Therapeutics, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.04+55.17%
+$0.01 (+55.17%) • Nov 11
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.82
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for EMHTF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.04 – $0.04
TARGET (TP)$0.05
STOP LOSS$0.04
RISK/REWARD1:19.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.63
52W High$0.07
52W Low$0.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $9.68M | $11.74M | $20.32M | $1.95M | $937,654 |
| Gross Profit | $-6,458,000 | $-9,670,000 | $-14,469,000 | $-3,099,000 | $-286,000 |
| Gross Margin | -66.7% | -82.4% | -71.2% | -159.1% | -30.5% |
| Operating Income | $-38,467,000 | $-37,783,000 | $-112,240,000 | $-30,382,000 | $-8,732,000 |
| Net Income | $-39,867,000 | $-43,539,000 | $-111,907,000 | $-30,983,000 | $-8,732,000 |
| Net Margin | -411.9% | -370.9% | -550.8% | -1590.5% | -931.3% |
| EPS | $-0.21 | $-0.23 | $-0.76 | $-0.22 | $-0.10 |
Company Overview
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
EMHTFBeat Rate
50%
Last 2 quarters
Avg Surprise
-21.2%
EPS vs Estimate
Beats / Misses
1/1
Last 12 quarters
Latest EPS
$-0.02
Q3 2022
EPS Surprise History
Q4 20
No data
Q4 20
No data
Q1 21
No data
Q3 21
No data
Q4 21
No data
Q4 21
No data
Q2 22
No data
Q3 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2022 | Nov 28, 2022 | — | — | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.05 | — | — |
Q4 2021 | Nov 29, 2021 | — | $-0.05 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.03 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.03 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.05 | — | — |
Q3 2020 | Aug 31, 2020 | — | $-0.08 | — | — |
Q2 2020 | Jun 18, 2020 | — | $-0.02 | — | — |
Q2 2020 | May 14, 2020 | — | $-0.45 | — | — |
Q4 2019 | Nov 29, 2019 | $-0.05 | $-0.12 | -140.0% | ✗ MISS |
Q3 2019 | Aug 29, 2019 | $-0.06 | $-0.00 | +97.6% | ✓ BEAT |
Q2 2019 | May 30, 2019 | — | $-0.03 | — | — |
Q2 2019 | May 3, 2019 | — | $-0.11 | — | — |
Q4 2018 | Nov 29, 2018 | — | $-0.04 | — | — |
Q3 2018 | Aug 30, 2018 | — | $-0.03 | — | — |
Q2 2018 | May 28, 2018 | — | $-0.04 | — | — |
Q2 2018 | Apr 2, 2018 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about EMHTF
What is EMHTF's current stock price?
Emerald Health Therapeutics, Inc. (EMHTF) is currently trading at $0.04 per share. The stock has moved +55.17% today.
What is the analyst price target for EMHTF?
No analyst price targets are currently available for this stock.
What sector is Emerald Health Therapeutics, Inc. in?
Emerald Health Therapeutics, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is EMHTF's market cap?
Emerald Health Therapeutics, Inc. has a market capitalization of N/A, making it a small-cap company.
Does EMHTF pay dividends?
No, Emerald Health Therapeutics, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBNOEF
Bionomics Limited
$0.01
Mkt Cap: $0.0B
CNPOF
RIV Capital Inc.
$0.08
Mkt Cap: $0.0B
FLWPF
The Flowr Corporation
$0.00
Mkt Cap: $0.0B
HBCNF
HealthBeacon plc
$0.50
Mkt Cap: $0.0B
IMUN
Immune Therapeutics, Inc.
$0.09
Mkt Cap: $0.0B
MGCLF
MGC Pharmaceuticals Limited
$0.27
Mkt Cap: $0.0B
MXDHF
MDxHealth S.A.
$0.25
Mkt Cap: $0.0B
TBPMF
Tetra Bio-Pharma Inc.
$0.00
Mkt Cap: $0.0B
TPPRF
Top Strike Resources Corp.
$0.04
Mkt Cap: $0.0B
VVCIF
VIVO Cannabis Inc.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to EMHTF for comparison